Reported nuclear target antigens in AIH are listed in Table 1; among them, it should be mentioned that a strong association between anti-Ro52 and anti-SLA has been reported: therefore, anti-SLA should be tested in anti-Ro52-positive patients with liver disease [21]. This evidence concerns the gene TRIM21 and autoimmune hepatitis.